Cargando…
Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity
AIM: In renal cell carcinoma (RCC), tumor heterogeneity generated challenges to biomarker development and therapeutic management, often becoming responsible for primary and acquired drug resistance. This study aimed to assess the inter-tumoral, intra-tumoral, and intra-lesional heterogeneity of know...
Autores principales: | Bersanelli, Melissa, Gnetti, Letizia, Pilato, Francesco Paolo, Varotti, Elena, Quaini, Federico, Campanini, Nicoletta, Rapacchi, Elena, Camisa, Roberta, Carbognani, Paolo, Silini, Enrico Maria, Rusca, Michele, Leonardi, Francesco, Maestroni, Umberto, Rizzo, Mimma, Brunelli, Matteo, Buti, Sebastiano, Ampollini, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501858/ https://www.ncbi.nlm.nih.gov/pubmed/37720351 http://dx.doi.org/10.37349/etat.2023.00165 |
Ejemplares similares
-
Pazopanib as a possible option for the treatment of metastatic
non-clear cell renal carcinoma patients: a systematic review
por: Bersanelli, Melissa, et al.
Publicado: (2020) -
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab
por: Bersanelli, Melissa, et al.
Publicado: (2019) -
Isolation and Characterization of Human Lung Lymphatic Endothelial Cells
por: Lorusso, Bruno, et al.
Publicado: (2015) -
MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study
por: Mozzoni, Paola, et al.
Publicado: (2017) -
From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis
por: Bersanelli, Melissa, et al.
Publicado: (2017)